Oral COVID-19 drug set to be produced by Hindustan Antibiotics Limited as experts also advise lung condition patients to get COVID jab

INDIA – Hindustan Antibiotics Limited (HAL), the Pimpri-based drug manufacturing unit, will produce oral medication to tackle mild COVID-19 cases in the next three months. This is a role the Indian government and public sector is set to undertake as a mitigative measure to help bolster the ailing health sector of the country. The decision was met after a review board meeting was held between the company board members and the union minister of state of ports, shipping and waterways, and chemicals and fertilizers. HAL is also hopeful in starting…

Read More